New Key Statistics Module, Z-Score and F-Score
SZSE:000919 Key Ratios
Market Cap ¥ M | 3,937.92 |
Enterprise Value ¥ M | 1,810.30 |
P/E(ttm) | 31.94 |
PE Ratio without NRI | 30.10 |
Forward PE Ratio | -- |
Price/Book | 1.03 |
Price/Sales | 1.12 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.48 |
Revenue (TTM) ¥ M | 2,823.00 |
EPS (TTM) ¥ | 0.20 |
Beneish M-Score | -2.22 |
10-y EBITDA Growth Rate % | -4.20 |
5-y EBITDA Growth Rate % | -11.30 |
y-y EBITDA Growth Rate % | -8.80 |
EV-to-EBIT | 14.98 |
EV-to-EBITDA | 14.98 |
PEG | -- |
Shares Outstanding M | 629.06 |
Net Margin (%) | 3.53 |
Operating Margin % | 3.00 |
Pre-tax Margin (%) | 4.27 |
Quick Ratio | 3.43 |
Current Ratio | 3.73 |
ROA % (ttm) | 2.12 |
ROE % (ttm) | 3.11 |
ROIC % (ttm) | 3.15 |
Dividend Yield % | 1.58 |
Altman Z-Score | 4.34 |
SZSE:000919 Number of Guru Trades
SZSE:000919 Volume of Guru Trades
Gurus Latest Trades with SZSE:000919
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000919 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jinling Pharmaceutical Co Ltd Insider Transactions
No Available Data